Runway Growth Finance Co-CEO Michael Rovner Buys $49.7K of Stock
Michael Rovner, Co-CEO, bought 7,500 shares of Runway Growth Finance Corp. at $6.63 a share, worth $49.7K in total on Nov 11, 2026. Shares held after the trade: 14,500 (+107.1%).
For the nine months ended September 30, 2026, Runway Growth Finance Corp. reported total investment income of $107.0 million and net investment income of $44.7 million. The company experienced a significant net realized loss of $44.0 million, primarily from non-control/non-affiliate investments, resulting in a net increase in net assets from operations of $3.1 million compared to $26.7 million in the prior year period.
Runway Growth Finance Corp. reported third quarter 2026 financial results with total investment income of $40.6 million and net investment income of $15.9 million ($0.38 per share). The company maintained a $1.1 billion investment portfolio and declared a fourth quarter dividend of $0.33 per share while repurchasing $4.8 million of its own stock.
Term
Q3 2026
“We are pleased to report solid third quarter results, reflecting strong earnings and stable NAV. We intentionally moderated originations during the quarter as we continued to optimize the balance sheet, but remain well positioned to capitalize on demand for venture debt financing as the innovation economy grows.”
David Spreng, Founder and Co-CEO
“It’s been an encouraging first few months at Runway as we continue to execute against our key priorities. We have made meaningful progress diversifying the portfolio, bringing leverage back within our target range and expanding our share repurchase program. Looking ahead, we will continue to take a disciplined approach to capital allocation, with shareholder value at the center of our decision-making.”
Runway Growth Finance Corp. declared a regular quarterly cash dividend of $0.33 per share for the fourth quarter of 2026. The dividend is payable on December 3, 2026, to stockholders of record as of November 17, 2026.
Runway Growth Finance Corp. provided a portfolio update for the quarter ended September 30, 2026, reporting $8.5 million in follow-on fundings across four existing portfolio companies. The company also experienced significant liquidity events totaling $139.4 million, driven by full repayments from 3PL Central, Route 92 Medical, Onward Medical, and Shepherd Intermediate.
Runway Growth Finance $46.3M Debt Financing with U.S. Bank Trust Company, National Association
Runway Growth Finance Corp. completed the issuance and sale of $46.3 million in 7.75% Notes due 2031. The notes are unsecured obligations maturing on October 1, 2031, and were issued under a Fifth Supplemental Indenture with U.S. Bank Trust Company as trustee.
Runway Growth Finance $45M Debt Financing with Oppenheimer & Co. Inc.
Runway Growth Finance Corp. entered into an underwriting agreement for the issuance and sale of $45.0 million in 7.75% Notes due 2031. The company also granted underwriters a 30-day option to purchase up to an additional $6.8 million in notes to cover overallotments.